DT
REGN icon

Diversified Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Diversified Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Sell
2,481
-23
-0.9% -$15.7K 0.02% 351
2026
Q1 		$1.93M Sell
2,504
-955
-28% -$731K 0.04% 263
2025
Q4 		$2.67M Sell
3,459
-388
-10% -$263K 0.05% 203
2025
Q3 		$2.16M Sell
3,847
-42
-1% -$23.7K 0.04% 242
2025
Q2 		$2.04M Buy
3,889
+1,015
+35% +$567K 0.05% 235
2025
Q1 		$1.82M Buy
2,874
+544
+23% +$374K 0.05% 228
2024
Q4 		$1.66M Buy
2,330
+1,123
+93% +$942K 0.04% 260
2024
Q3 		$1.27M Sell
1,207
-2
-0.2% -$2.23K 0.03% 320
2024
Q2 		$1.27M Buy
1,209
+22
+2% +$21.3K 0.04% 274
2024
Q1 		$1.14M Buy
1,187
+18
+2% +$17.1K 0.03% 290
2023
Q4 		$1.03M Sell
1,169
-207
-15% -$170K 0.03% 285
2023
Q3 		$1.13M Buy
1,376
+8
+0.6% +$6.29K 0.04% 238
2023
Q2 		$983K Buy
1,368
+14
+1% +$10.8K 0.04% 282
2023
Q1 		$1.11M Buy
1,354
+35
+3% +$26.4K 0.04% 234
2022
Q4 		$952K Sell
1,319
-7
-0.5% -$5.17K 0.04% 247
2022
Q3 		$913K Sell
1,326
-38
-3% -$23.9K 0.04% 229
2022
Q2 		$806K Buy
1,364
+51
+4% +$33.2K 0.03% 272
2022
Q1 		$917K Sell
1,313
-321
-20% -$203K 0.03% 278
2021
Q4 		$1.03M Sell
1,634
-64
-4% -$39.3K 0.03% 252
2021
Q3 		$1.03M Buy
1,698
+114
+7% +$70.8K 0.04% 219
2021
Q2 		$885K Sell
1,584
-531
-25% -$269K 0.03% 261
2021
Q1 		$1M Buy
2,115
+853
+68% +$415K 0.04% 216
2020
Q4 		$610K Buy
1,262
+216
+21% +$117K 0.02% 292
2020
Q3 		$586K Buy
1,046
+307
+42% +$186K 0.03% 278
2020
Q2 		$461K Sell
739
-10
-1% -$5.68K 0.02% 273
2020
Q1 		$366K Buy
749
+14
+2% +$5.78K 0.02% 266
2019
Q4 		$276K Buy
+735
New +$247K 0.01% 356
2019
Q1 		– Sell
-3,630
Closed -$1.36M – 367
2018
Q4 		$1.36M Buy
3,630
+30
+0.8% +$11K 0.08% 93
2018
Q3 		$1.46M Hold
3,600
– – 0.07% 92
2018
Q2 		$1.24M Sell
3,600
-5
-0.1% -$1.56K 0.08% 98
2018
Q1 		$1.24M Hold
3,605
– – 0.08% 94
2017
Q4 		$1.35M Hold
3,605
– – 0.08% 95
2017
Q3 		$1.61M Sell
3,605
-1,595
-31% -$759K 0.12% 84
2017
Q2 		$2.55M Sell
5,200
-805
-13% -$352K 0.21% 53
2017
Q1 		$2.33M Buy
6,005
+1,893
+46% +$702K 0.18% 61
2016
Q4 		$1.51M Buy
+4,112
New +$1.56M 0.13% 86
2016
Q3 		– Sell
-2,295
Closed -$801K – 345
2016
Q2 		$801K Sell
2,295
-1,010
-31% -$389K 0.09% 187
2016
Q1 		$1.19M Sell
3,305
-26
-0.8% -$10.7K 0.13% 156
2015
Q4 		$1.81M Sell
3,331
-829
-20% -$449K 0.19% 117
2015
Q3 		$1.94M Sell
4,160
-400
-9% -$215K 0.21% 117
2015
Q2 		$2.33M Sell
4,560
-710
-13% -$346K 0.22% 110
2015
Q1 		$2.38M Hold
5,270
– – 0.21% 111
2014
Q4 		$2.16M Buy
+5,270
New +$2.07M 0.2% 125
2014
Q2 		$1.76M Buy
+6,215
New +$1.84M 0.15% 172
2013
Q4 		$1.31M Sell
4,747
-876
-16% -$252K 0.13% 155
2013
Q3 		$1.76M Buy
5,623
+1,488
+36% +$391K 0.19% 110
2013
Q2 		$930K Buy
+4,135
New +$963K 0.11% 187

Other funds holding REGN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Diversified Trust's REGN Position: Q2 2026 in Review

Diversified Trust reduced its Regeneron Pharmaceuticals (REGN) stake by 0.92% in Q2 2026, selling an estimated $15.7K and leaving 2,481 shares worth $1.55M. The position accounts for 0.02% of the portfolio, ranked #351.

Diversified Trust first reported a position in REGN in Q2 2013 and has held it in 47 quarters since. The position peaked at $2.67M in Q4 2025. 208 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Diversified Trust held 2,481 shares of Regeneron Pharmaceuticals worth $1.55M as of Q2 2026.
  • Diversified Trust sold 23 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $15.7K.
  • Regeneron Pharmaceuticals made up 0.02% of Diversified Trust's portfolio in Q2 2026, its #351 holding.
  • Diversified Trust first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 47 quarters since.
  • Diversified Trust's Regeneron Pharmaceuticals position peaked at $2.67M in Q4 2025.
  • 208 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.